ConductScience.org, home

Trial · NCT02832401

The Impact of Caffeine on Cognition in Schizophrenia

NCT02832401, Not applicable, Completed, Nova Scotia Health Authority

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Impact of Caffeine on Cognition in Schizophrenia. Trials, record NCT02832401. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02832401

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Impact of Caffeine on Cognition in Schizophrenia
NCT number
NCT02832401
Status
Completed
Phases
Not applicable
Enrollment
24 participants, actual
Lead sponsor
Nova Scotia Health Authority
Conditions
Schizophrenia, Caffeine
Interventions
Caffeine, Placebo
First posted
2016-07-14
Last updated
2022-11-15

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryEvent-related potentials (ERPs)30 minutes post-intervention during both test sessionsAverage neuroelectric brain response measured in microvolts. Event-related potentials include N2pc (visual search) and P300 (visual search, AX-CPT and N-Back)
SecondaryResponse accuracy30 minutes post-intervention during both test sessions% of correct responses during performance of visual search, AX-CPT and N-Back
SecondaryReaction Time30 minutes post-intervention during both test sessionsAverage time from target appearance to correct behavioural response (measured in milliseconds) during performance of visual search, AX-CPT and N-Back
SecondaryFalse alarms30 minutes post-intervention during both test sessionsNumber of responses to non-target stimuli during performance of visual search, AX-CPT and N-Back
Secondaryd'30 minutes post-intervention during both test sessionsA measure of signal detection sensitivity, obtained by the following formula: d' = zHits = zFalseAlarms, during performance of visual search, AX-CPT and N-Back
SecondaryC30 minutes post-intervention during both test sessionsA measure of response bias, obtained by the following formula: C = -0.5(zHits + zFA), during performance of visual search, AX-CPT and N-Back
SecondaryChecklist of Drug Related Symptoms1 hour post-intervention during both sessionsAssesses physical symptoms potentially arising due to drug administration, including nausea and headache

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers53

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
739083BACKGROUNDPubMed
1488111BACKGROUNDPubMed
1751869BACKGROUNDPubMed
2375945BACKGROUNDPubMed
3222359BACKGROUNDPubMed
3597168BACKGROUNDPubMed
5146491BACKGROUNDPubMed
6214611BACKGROUNDPubMed
8481748BACKGROUNDPubMed
8601555BACKGROUNDPubMed

1 to 10 of 53

See all 53 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
1-Back TaskPrimary outcomeConductCognition
2-Back TaskPrimary outcomeConductCognition
AX Continuous Performance TestPrimary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02832401

GET https://conductscience.org/api/trials/v1/NCT02832401/papers?page=2